Cyanotech earnings nearly triple
for quarter

The profit helped the Big Isle company post
yearly results of $2.5 million

By Rob Perez
Star-Bulletin



Cyanotech Corp. today said it nearly tripled its fourth-quarter earnings, capping a record year for the Big Island biotech company.

For the quarter ended March 31, the company reported a prof it of $780,000, or 5 cents a share, up from $266,000, or 2 cents a share, in the year-earlier period. Revenues totaled $2.1 million, a 71.6 percent increase.

For the year, Cyanotech earned a record $2.5 million, or 17 cents a share, compared with a $769,000 profit, or 5 cents a share, in the previous year. Revenues jumped 95 percent, to $8.1 million.

Gerald Cysewski, the company's chief executive, attributed the results to increased demand for its principal product, Spirulina Pacifica, a nutritional supplement.

Cyanotech develops and sells nutritional products made from microalgae grown in ponds.

To keep pace with demand, Cysewski said, the company invested more than $4.2 million during the year in additional manufacturing capacity. It recently sold stock to the public to raise $10 million for expansion and product development.

In January, the company began producing a natural red pigment targeted for the aquaculture industry, which now uses synthetic pigments to give a pinkish color to the flesh of pen-raised fish and shrimp.

It also obtained a license to make and sell a natural bacterial toxin the company believes will be a safe mosquito-control agent when applied to infested waters.




Text Site Directory:
[News] [Business] [Features] [Sports] [Editorial] [Community] [Info] [Stylebook] [Feedback]